Rahul Aras und Ceo Of Iterion - Info zur Person

(1 - 7 von 7

)

Iterion The…utics Announces Initiation of Phase Yahoo Financefinance.yahoo.com › news › iterion-the…utics-an...

· ... a potential new treatment for AML, the most common type of leukemia in …s," stated Rahul Aras, Ph.D., CEO of Iterion The…utics.

Iterion The…utics - Tegavivint Phase 2 Clinical Trial

Dr. Rahul Aras, CEO of Iterion The…utics, discusses the company's lead product, Tegavivint, a unique nuclear β-catenin inhibitor

Iterion The…utics Announces Presentation of Three Posters ...www.preipopharma.com › press-releases › Iterion-T...

... multiple poster presentations at AACR 2022; particularly the results of our first-in-man Phase 1 clinical study," said Rahul Aras, PhD, CEO of Iterion.

Iterion The…utics Announces Initiation of Phase 1/2 Clinical Trial ...www.drugs.com › clinical_trials › iterion-the…uti...

· ... Phase 1/2 clinical trial of tegavivint as a potential targeted treatment for pediatric cancers," said Rahul Aras, Ph.D., CEO of Iterion.

Person "Aras" (1)
Vorname "Rahul" (988)
Name "Aras" (1138)

sortiert nach Relevanz / Datum

Erweiterte Suche

Person-Suchen: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Rahul Aras und Ceo Of Iterion Person-Info

Iterion The…utics Announces Initiation of Phase Yahoo Financefinance.yahoo.com › news › iterion-the…utics-an...

Iterion The…utics - Tegavivint Phase 2 Clinical Trial

Iterion The…utics Announces Presentation of Three Posters ...www.preipopharma.com › press-releases › Iterion-T...

Iterion The…utics Announces Initiation of Phase 1/2 Clinical Trial ...www.drugs.com › clinical_trials › iterion-the…uti...

Iterion The…utics Hires Jean Chang as Chief Operating Officeraithority.com › cognitive-science › neuroscience › it...

The Decision To Follow A Mentor From Vanderbilt To NYUwww.lifescienceleader.com › doc › the-decision-to-f...

Alle Infos zum Namen "Rahul Aras"